Step-by-Step Treatment Guidelines for Asthma and COPD in Canada
I can provide comprehensive COPD treatment guidelines based on the Canadian Thoracic Society evidence, but the provided evidence does not contain specific Canadian asthma treatment guidelines, so I cannot give you a complete step-by-step asthma protocol from these sources.
COPD Treatment Algorithm (Canadian Guidelines)
Step 1: Confirm Diagnosis with Spirometry
You must obtain spirometry showing airflow obstruction that is not fully reversible 1. The critical diagnostic feature is FEV1/FVC ratio demonstrating obstruction that persists after bronchodilator therapy 2.
Step 2: Smoking Cessation (Most Important Intervention)
Stop smoking immediately - this is the single most effective intervention to slow disease progression 1. Provide structured support and follow-up. In 90% of cases, chronic sputum production will cease after quitting 2.
Step 3: Initial Bronchodilator Therapy
Start with short-acting bronchodilators (SABA or SAMA) as needed for symptom relief 1.
- Use either short-acting beta-agonists or short-acting anticholinergics
- Ensure proper inhaler technique from the start
- Reassess device choice if patient cannot use it effectively
Step 4: Escalate to Long-Acting Bronchodilators
If symptoms persist despite short-acting therapy, prescribe long-acting bronchodilators 1.
For moderate to severe COPD, use long-acting muscarinic antagonist (LAMA) over short-acting options (Grade 1A) 3. LAMAs reduce both moderate exacerbations (requiring steroids/antibiotics) and severe exacerbations (requiring hospitalization), plus improve quality of life and lung function with fewer serious adverse events 3.
Alternative effective options 3:
- LAMA monotherapy, OR
- LAMA + LABA combination, OR
- ICS/LABA combination
All three approaches effectively prevent exacerbations (Grade 1C).
Step 5: Add Inhaled Corticosteroids (ICS) - Specific Criteria
Do NOT use ICS as first-line therapy 1.
Add ICS/LABA combination therapy if the patient has:
- Moderate to very severe COPD (FEV1 <60% predicted), AND
- Recurrent exacerbations (≥2 per year or ≥1 requiring hospitalization)
This combination reduces exacerbations, improves quality of life, reduces dyspnea, and improves lung function compared to LABA alone (Grade 1C) 3. Accept the increased risk of oral candidiasis, upper respiratory infections, and pneumonia as trade-offs for exacerbation prevention 3.
Step 6: Consider Triple Therapy for Severe Disease
For patients with very severe COPD who remain symptomatic or continue having exacerbations on dual therapy, escalate to triple therapy: LAMA + ICS + LABA (Grade 2C) 3.
Step 7: Non-Pharmacological Interventions
Prescribe pulmonary rehabilitation for all symptomatic patients - this improves symptoms, activity levels, and quality of life even in severe COPD 1.
Assess for long-term oxygen therapy (LTOT) in patients with:
- Severe COPD with respiratory failure
- Measure arterial blood gases to determine eligibility 2
Treatment of COPD Exacerbations
Home Treatment Criteria
Treat at home if the patient has:
- Mild breathlessness
- Good general condition
- Not on LTOT
- Good activity level
- Good social circumstances
The more "no" answers, the more likely hospital admission is needed 2.
Home Treatment Protocol (3-Step Approach)
Step 1: Increase bronchodilators 2
- Add or increase dose
- Verify inhaler device is appropriate and technique is correct
- Nebulizers usually not required
Step 2: Prescribe antibiotics IF 2 or more of these are present: 2
- Increased breathlessness
- Increased sputum volume
- Development of purulent sputum
Step 3: Add oral corticosteroids in selected cases 2
- Use only when clinically indicated (guidelines don't specify exact criteria but imply more severe presentations)
- Short course only
Follow-Up After Home Treatment
If patient deteriorates: Reassess immediately and consider hospital admission 2.
If not fully improved in 2 weeks: Order chest X-ray and refer to hospital 2.
At follow-up visit, measure: 2
- FEV1
- Inhaler technique
- Patient understanding of treatment
- Reinforce smoking cessation, weight management, exercise
Post-Hospitalization Follow-Up
Schedule assessment 4-6 weeks after discharge 2:
- Assess ability to cope at home
- Measure FEV1
- Reassess inhaler technique and treatment understanding
- Evaluate need for LTOT and/or home nebulizer in severe COPD
- Continue regular stable COPD follow-up thereafter
Key Pitfalls to Avoid
Common Mistake #1: Using ICS as first-line therapy - this is explicitly not recommended 1. Start with bronchodilators.
Common Mistake #2: Prescribing antibiotics for every exacerbation - only use when ≥2 of the three criteria are met (increased breathlessness, sputum volume, purulent sputum) 2.
Common Mistake #3: Failing to confirm diagnosis with spirometry - clinical symptoms alone are insufficient 2, 1.
Common Mistake #4: Not prioritizing smoking cessation - this remains more important than any medication 1.
Common Mistake #5: Isolated PEF measurements for monitoring - these have poor correlation with FEV1 in COPD; use spirometry instead 2.
When to Refer to Specialist
Refer for specialist assessment if: 2
- Age <40 years with COPD (screen for alpha-1 antitrypsin deficiency)
- Uncertain diagnosis
- Suspected severe COPD needing treatment optimization
- Onset of cor pulmonale
- Assessment for oxygen therapy needed
- Rapid FEV1 decline (>500 mL over 5 years)
- Frequent infections (exclude bronchiectasis)
- Symptoms disproportionate to lung function
- Bullous lung disease (surgical candidate assessment)
Note on Asthma Guidelines: The evidence provided focuses heavily on COPD management from Canadian sources. While 4 discusses asthma care gaps in Canada, it does not provide step-by-step treatment algorithms. For comprehensive Canadian asthma treatment guidelines, you would need to consult the Canadian Thoracic Society Asthma Guidelines or similar dedicated asthma resources not included in this evidence set.